Cardinal Health
CAH
272.81
+0.47
+0.17%
Cardinal Health
US · CAH
#429 by market cap
Listed 1970
272.81
+0.47
+0.17%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Quant vs Street three independent views, side by side
StockVane factor grade
B
Momentum strategy signal
Hold
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: Citi moved from Hold to Buy on 2026-01-09.
Analyst consensus 12 analysts
Buy
Avg price target 303.00 +11.1%
Price target rangecurrent 272.81
Low270.00
Avg303.00
High321.00
Buy 92%
Hold 8%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-17 | Wells Fargo | -- | Buy | 321.00 |
| 2026-11-17 | Barclays | -- | Buy | 320.00 |
| 2026-11-11 | Argus Research | -- | Buy | 309.00 |
| 2026-11-10 | BofA Securities | -- | Buy | 320.00 |
| 2026-11-10 | J.P. Morgan | -- | Hold | 286.00 |
| 2026-11-09 | TD Cowen | -- | Buy | 304.00 |
| 2026-11-06 | UBS | -- | Buy | 310.00 |
| 2026-11-06 | Morgan Stanley | -- | Buy | 306.00 |
| 2026-11-06 | Barclays | -- | Buy | 275.00 |
| 2026-11-05 | Mizuho Securities | -- | Buy | 290.00 |
| 2026-11-05 | Baird | -- | Buy | 305.00 |
| 2026-11-05 | Evercore | -- | Buy | 270.00 |
| 2026-11-05 | RBC Capital | -- | Buy | 295.00 |
| 2026-10-30 | Morgan Stanley | -- | Buy | 286.00 |
| 2026-10-27 | Barclays | -- | Buy | 275.00 |
| 2026-10-20 | Mizuho Securities | -- | Buy | 280.00 |
| 2026-10-16 | UBS | -- | Buy | 295.00 |
| 2026-10-12 | RBC Capital | -- | Buy | 276.00 |
| 2026-10-06 | RBC Capital | -- | Buy | 276.00 |
| 2026-09-09 | Wells Fargo | -- | Buy | 277.00 |
| 2026-08-19 | RBC Capital | -- | Buy | 276.00 |
| 2026-08-18 | Barclays | -- | Buy | 275.00 |
| 2026-08-17 | J.P. Morgan | -- | Hold | 260.00 |
| 2026-08-13 | TD Cowen | -- | Buy | 280.00 |
| 2026-08-13 | Mizuho Securities | -- | Buy | 250.00 |
Price target trend monthly average, last 3 years
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-01-09 | Citi | Hold → Buy | 244.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2027/Q1 | 2026-11-05 | -- | ±4.74% | +2.25% (in line) |
| 2026/Q4 | 2026-08-11 | -- | ±6.09% | +1.30% (in line) |
| 2026/Q3 | 2026-04-30 | -- | ±6.45% | -4.90% (in line) |
| 2026/Q2 | 2026-02-05 | -- | ±4.68% | +9.83% (beat) |
| 2026/Q1 | 2025-10-30 | -- | ±4.16% | +15.43% (beat) |
| 2025/Q4 | 2025-08-12 | -- | ±4.52% | -7.21% (beat) |
| 2025/Q3 | 2025-05-01 | -- | ±5.46% | +3.00% (in line) |
| 2025/Q2 | 2025-01-30 | -- | ±4.50% | +0.39% (in line) |
| 2025/Q1 | 2024-11-01 | -- | ±6.04% | +7.01% (beat) |
| 2024/Q4 | 2024-08-14 | -- | ±5.43% | +3.68% (in line) |
| 2024/Q3 | 2024-05-02 | -- | ±3.86% | +0.79% (in line) |
| 2024/Q2 | 2024-02-01 | -- | ±4.19% | -3.75% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:02:34 · For reference only, not investment advice and not tailored to your situation.
Cardinal Health discussion 0 comments